SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-157839
Filing Date
2024-06-10
Accepted
2024-06-10 07:13:33
Documents
17
Period of Report
2024-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793909d8k.htm   iXBRL 8-K 34367
2 EX-99.1 d793909dex991.htm EX-99.1 15995
7 GRAPHIC g793909dsp1.jpg GRAPHIC 4518
8 GRAPHIC g793909page1.jpg GRAPHIC 18631
  Complete submission text file 0001193125-24-157839.txt   260856

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cnta-20240605.xsd EX-101.SCH 3285
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20240605_def.xml EX-101.DEF 14707
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20240605_lab.xml EX-101.LAB 24578
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20240605_pre.xml EX-101.PRE 15665
20 EXTRACTED XBRL INSTANCE DOCUMENT d793909d8k_htm.xml XML 6258
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 241031445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)